🇩🇪 TRASTUZUMAB DERUXTECAN in Germany

TRASTUZUMAB DERUXTECAN (TRASTUZUMAB DERUXTECAN) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Enhertu
  • Status: approved

TRASTUZUMAB DERUXTECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB DERUXTECAN approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB DERUXTECAN in Germany?

Marketing authorisation holder not available in our data.